Send to

Choose Destination
Cytokine. 2015 Sep;75(1):25-37. doi: 10.1016/j.cyto.2015.05.008. Epub 2015 Jun 11.

The differential expression of IL-4 and IL-13 and its impact on type-2 immunity.

Author information

Department of Immunology, Duke University Medical Center, Durham, NC 27710, United States.
Department of Immunology, Duke University Medical Center, Durham, NC 27710, United States. Electronic address:


Allergic disease represents a significant global health burden, and disease incidence continues to rise in urban areas of the world. As such, a better understanding of the basic immune mechanisms underlying disease pathology are key to developing therapeutic interventions to both prevent disease onset as well as to ameliorate disease morbidity in those individuals already suffering from a disorder linked to type-2 inflammation. Two factors central to type-2 immunity are interleukin (IL)-4 and IL-13, which have been linked to virtually all major hallmarks associated with type-2 inflammation. Therefore, IL-4 and IL-13 and their regulatory pathways represent ideal targets to suppress disease. Despite sharing many common regulatory pathways and receptors, these cytokines perform very distinct functions during a type-2 immune response. This review summarizes the literature surrounding the function and expression of IL-4 and IL-13 in CD4+ T cells and innate immune cells. It highlights recent findings in vivo regarding the differential expression and non-canonical regulation of IL-4 and IL-13 in various immune cells, which likely play important and underappreciated roles in type-2 immunity.


Follicular T-helper cell; Interleukin-13; Interleukin-4; Th2 cell; Type-2 immunity

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center